182 related articles for article (PubMed ID: 18032774)
1. More on cetuximab in head and neck cancer.
Mell LK; Weichselbaum RR
N Engl J Med; 2007 Nov; 357(21):2201-2; author reply 2202-3. PubMed ID: 18032774
[No Abstract] [Full Text] [Related]
2. Cetuximab and radiotherapy for head and neck cancer.
Posner MR; Wirth LJ
N Engl J Med; 2006 Feb; 354(6):634-6. PubMed ID: 16467552
[No Abstract] [Full Text] [Related]
3. Cetuximab plus radiotherapy for head and neck cancer.
Armstrong JG
N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710907
[No Abstract] [Full Text] [Related]
4. Cetuximab plus radiotherapy for head and neck cancer.
Cengiz M; Yildiz F; Genc M
N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710908
[No Abstract] [Full Text] [Related]
5. Manageable early toxicity of cetuximab concurrent with radical radiotherapy for locally advanced head and neck cancer.
Wieczorek A; Hamid A; O'Toole L
Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):496. PubMed ID: 21482459
[No Abstract] [Full Text] [Related]
6. Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.
Teoh DC; Rodger S; Say J; Hartley A
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):717. PubMed ID: 18757187
[No Abstract] [Full Text] [Related]
7. Cetuximab plus radiotherapy for head and neck cancer.
Ho AC
N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16707760
[No Abstract] [Full Text] [Related]
8. Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer.
Chan A; Teoh D; Sanghera P; Hartley A
Radiother Oncol; 2009 Dec; 93(3):654. PubMed ID: 19524312
[No Abstract] [Full Text] [Related]
9. Cetuximab plus radiotherapy for head and neck cancer.
Hartig F; Pechlaner C
N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710909
[No Abstract] [Full Text] [Related]
10. Treatment of advanced head and neck cancer with cetuximab.
Merlano M; Garrone O
Int J Biol Markers; 2007; 22(1 Suppl 4):S71-6. PubMed ID: 17520584
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
Bonner JA; Harari PM; Giralt J; Azarnia N; Shin DM; Cohen RB; Jones CU; Sur R; Raben D; Jassem J; Ove R; Kies MS; Baselga J; Youssoufian H; Amellal N; Rowinsky EK; Ang KK
N Engl J Med; 2006 Feb; 354(6):567-78. PubMed ID: 16467544
[TBL] [Abstract][Full Text] [Related]
12. Cetuximab in squamous cell head and neck carcinomas.
Gebbia V; Giuliani F; Valori VM; Agueli R; Colucci G; Maiello E
Ann Oncol; 2007 Jun; 18 Suppl 6():vi5-7. PubMed ID: 17591832
[TBL] [Abstract][Full Text] [Related]
13. Are anti-vitamin K drugs contraindicated with cetuximab during head-and-neck cancer concomitant radiotherapy?
Brohée D; Henry AR; Castadot P
Acta Clin Belg; 2013; 68(3):237-9. PubMed ID: 24156231
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab and cisplatin for chemotherapy-refractory squamous cell cancer of the head and neck.
Burtness B
J Clin Oncol; 2005 Aug; 23(24):5440-2. PubMed ID: 16009959
[No Abstract] [Full Text] [Related]
15. Cetuximab for colorectal cancer.
van der Spek E; Sonke GS
N Engl J Med; 2008 Mar; 358(11):1196; author reply 1196-7. PubMed ID: 18340661
[No Abstract] [Full Text] [Related]
16. [Role of targeted therapy in the treatment of squamous cell head and neck cancer].
Gyergyay F
Magy Onkol; 2007; 51(2):155-7. PubMed ID: 17660872
[TBL] [Abstract][Full Text] [Related]
17. Head and neck cancer: integrating anti-EGFR treatment with standard therapy.
Kies MS
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S52-9. PubMed ID: 19780246
[TBL] [Abstract][Full Text] [Related]
18. Cetuximab-induced pneumonitis in head and neck cancer patient.
De Vos FY; Driessen CM; Jaspers HC; van Herpen CM; Simons B
Oral Oncol; 2012 Jun; 48(6):e17-8. PubMed ID: 22342570
[No Abstract] [Full Text] [Related]
19. Cetuximab approved by FDA for treatment of head and neck squamous cell cancer.
Cancer Biol Ther; 2006 Apr; 5(4):340-2. PubMed ID: 16808060
[No Abstract] [Full Text] [Related]
20. Evaluation of Cetuximab in combination with radiotherapy or chemotherapy against advanced squamous cell carcinoma of the head and neck.
Li JZ; Zheng JW; Zhang ZY
Shanghai Kou Qiang Yi Xue; 2008 Feb; 17(1):1-5. PubMed ID: 18360658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
